News
November 3, 2023

Fowler honored by IUPUI as Research Frontiers Trailblazer

Nicole Fowler, PhD

Regenstrief Institute Research Scientist Nicole Fowler, PhD, MHSA, has been honored as a 2023 IUPUI Research Frontiers Trailblazer. The annual award from IUPUI’s vice chancellor for research recognizes associate professors who have made exceptional contributions to their research field in the first three years of their academic appointment.

Dr. Fowler is committed to advancing research that will be relevant to patients and families facing healthcare choices and researches the development, testing and comparison of evidence-based and patient-centered interventions that improve the quality of care for older adults and their family caregivers. Her work mainly focuses on medical decision-making interventions to support family caregivers of individuals living with Alzheimer’s disease and related dementias and person-centered approaches to early detection.

“Over 6 million people in the United States have Alzheimer’s disease and there are close to 15 million unpaid caregivers. The implications of my work are focusing on a huge number of people that oftentimes get overlooked,” said Dr. Fowler.

Dr. Fowler’s work includes early detection, identifying therapies and clinical trials, and ensuring patients have the healthcare and the social support they need. She brings together the science of early detection of Alzheimer’s disease and related dementias and how to support older adults and their family members.

About Nicole Fowler, PhD, MHSA 
In addition to her role as associate director and a research scientist at the Indiana University Center for Aging Research at Regenstrief Institute, Nicole R. Fowler, PhD, MHSA, is also an associate professor of medicine at Indiana University School of Medicine, director of research for the Division of General Internal Medicine and Geriatrics, and an implementation scientist in the Center for Health Innovation and Implementation Science.

About Regenstrief Institute
Founded in 1969 in Indianapolis, the Regenstrief Institute is a local, national and global leader dedicated to a world where better information empowers people to end disease and realize true health. A key research partner to Indiana University, Regenstrief and its research scientists are responsible for a growing number of major healthcare innovations and studies. Examples range from the development of global health information technology standards that enable the use and interoperability of electronic health records to improving patient-physician communications, to creating models of care that inform clinical practice and improve the lives of patients around the globe.

Sam Regenstrief, a nationally successful entrepreneur from Connersville, Indiana, founded the institute with the goal of making healthcare more efficient and accessible for everyone. His vision continues to guide the institute’s research mission.

Related News

infographic showing findings of study

Examining how insurance coverage shapes access to kidney transplantation

Regenstrief researchers contribute to a national study highlighting differences between Medicare Advantage and traditional Medicare  For people with kidney

Tarik Yuce, MD, Jiang Bian, PhD, Serena Guo, MD, PhD, Xing He, PhD, Yu Huang, PhD

GLP-1 medications linked to greater loss of regained weight after bariatric surgery

Study involving Regenstrief researchers uses real-world evidence to evaluate an option for managing weight recurrence  People who regain weight

image of a doctor consulting with a patient

Scalable approach could improve early detection of cognitive impairment in primary care

Regenstrief-led study evaluates how existing health data and patient-reported information could help clinicians identify individuals who need further assessmentEarly

Christopher Callahan, MD

Regenstrief Institute scientist named next president and CEO of Regenstrief Foundation 

Longtime Regenstrief investigator and former IU Center for Aging Research director will assume Foundation leadership in summer 2027.  Christopher